PRISM Program for Stress Management in Young Cancer Survivors

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Recruiting N/A Interventional Study
Stress Anxiety
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 25
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
325 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Who this trial is looking for

This trial is looking for young people aged 12 to 25 who have finished their main cancer treatment. Participants will use a mobile app program to learn skills that help manage stress and improve resilience after dealing with cancer.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 12 and 25 years old.
  • I can speak English or Spanish.
  • I can read English or Spanish.
  • I can understand and participate in the PRISM sessions.
  • I have completed my main cancer treatment.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this study is to find the best way to help participants and families manage the stress of facing a serious illness and be better able to "bounce back" or be resilient after a difficult situation. Participants will take part in the "Promoting Resilience in Stress Management" PRISM program, which is designed to provide skills to change or improve the impact of stress in everyday life. T…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Participants that have completed their main cancer-directed therapy at one of the study sites affiliated centers who meet all the eligibility criteria will be eligible for participation in this study. Inclusion Criteria: * All genders ≥ 12 and ≤ 25 years of age at baseline * Participant is able to…
Contacts

Abby Rosenberg, MD

206-987-6892

AbbyR_Rosenberg@DFCI.HARVARD.EDU

CONTACT